Enovis's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Enovis's ROA in the second quarter of 2026?
Enovis Corp had a negative return on assets (ROA) of -27.88%, due to the net loss of $-1 billion, during the twelve months ending in the second quarter of 2026.

However, within the Healthcare sector 408 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jul 03 2026 quarter, so far to 3574, from total ROA ranking in the first quarter of 2026 at 4196.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jul 03 2026) II. Quarter	(Apr 03 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Oct 03 2025) III. Quarter	(Jul 04 2025) II. Quarter
Y / Y Total Assets Change	-24.04 %	-20.35 %	-17.57 %	-20.51 %	-7.78 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-1,101	-1,136	-1,184	-1,366	-827
Return On Assets (TTM)	-27.88 %	-26.76 %	-26.35 %	-29.1 %	-16.61 %
ENOV's Total Ranking	# 3574	# 4196	# 3734	# 3486	# 3516
Total Assets (TTM) in million	3,766	3,832	3,835	4,363	4,958
Seq. Total Assets Change	-1.73 %	-0.06 %	-12.11 %	-12 %	3.04 %
Seq. Net Income Change	-	-	-	-	-

ENOV's 5 Years Annual ROA >> Back to ENOV Management Effectiveness >> Compare ENOV ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 125
Sector	# 409
Overall	# 3570

Return On Assets Statistics
High	Average	Low
5.7 %	-2.27 %	-28.69 %
(Dec 31 2014)		(Oct 03 2025)

News about Enovis Corp Return on Assets ROA

Innovations in Surgical Technologies Enovis Strengthens Leadership and Expands Product Portfolio

In the dynamic landscape of medical technology, innovation is the bedrock on which successful companies are built. Enovis, a prominent player in the sector and listed on the New York Stock Exchange under the ticker ENOV, continues to exemplify this principle through strategic leadership appointments and groundbreaking product advancements. Recently, the company announced the appointment of Tim Czartoski as President of its U.S. Surgical and Global Product and Enabling Technologies division, a move aimed at bolstering its presence in the surgical sector. Additionally, Enovis made significant strides in revision knee surgery with the introduction of its EMPOWR Cones, demonstrating its commitment to innovative surgical solutions. Leadership Appointment: A Strategic MoveTim Czartoski s appointment as President reflects a strategic initiative to reinforce Enovis s U.S. Surgical business. With his vast experience and proven track record in the medical technology industry, Czartoski is poised to lead the company’s global surgical product engine and enabling technologies. Reporting to Louie Vogt, the Group President of the Enovis Reconstructive Business Group, Czartoski s leadership is expected to drive operational excellence, foster innovation, and enhance the efficacy of surgical solutions for healthcare providers and patients alike.

Financial Statements
Enovis's Assets	$ 3,766 million	ENOV's Balance sheet
Enovis's Income	$ -1 million	Quarterly ENOV's Income Statement
ENOV's Income by Division		See ENOV's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-17.57 %	4.57 %	5.69 %	-49.49 %	16.04 %
Total Assets in million	3,835	4,652	4,449	4,209	8,332
Y / Y Net Income Change	-	-	-	-	66.65 %
Net Income in million	-1,184	-825	-33	-12	76
Annual Return On Assets	-30.87 %	-17.73 %	-0.74 %	-0.28 %	0.92 %

ENOV's 5 Years Annual ROA >> Back to ENOV Management Effectiveness >> Compare ENOV ROA to its Competitors

More Return On Assets Ratios
ENOV's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ENOV's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ENOV's Competitors
Subscribers only: Roa for Enovis's Suppliers
Subscribers only: Return On Assets for ENOV's Customers

You may also want to know
ENOV's Roi	ENOV's Inventory Turnover Ratio	ENOV's Growth Rates	ENOV's Dividend Comparisons
	ENOV's Profitability Ratios	ENOV's Asset Turnover Ratio	ENOV's Dividend Growth
ENOV's Roe	ENOV's Valuation Ratios	ENOV's Financial Strength Ratios	ENOV's Dividend Payout Ratio

Companies with similar Return On Assets at Jul 03 2026, within Healthcare Sector

ROA

Date modified: 2026-09-12T06:12:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.